This is a demo store. No orders will be fulfilled.
Collaborations across Immunotherapy - Genetic TOE
Collaborations across Immunotherapy - Genetic TOE
16-Sep-2016
Global
Description
This edition of the Genetic Technology TOE depicts the current landscape and the new life sciences trends across immunotherapy. The corresponding patent scenario is depicted along with the industry interactions.
The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants.
The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.
Keywords: Checkpoint inhibitor therapies, immunotherapy, chimeric antigen, cell receptor, small molecule kinase
Table of Contents
Prominent Immuno-oncology Collaborations
- Drug Discovery Platform Used to Develop Checkpoint Inhibitor Therapies
- Using Chimeric Antigen and Cell Receptor Technologies to Develop Immunotherapies
- Using Small Molecule Kinase Technology to Develop Therapeutics for Immunotherapy
- Innovative Cancer Therapies Developed for Immuno-oncology Pipelines
Appendix
- Patent Scenario
- Industry Interactions
Popular Topics
No Index | No |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | D758-00-25-00-00 |
Is Prebook | No |
Ti Codes | D758 |